EU CPNP Cosmetic Regulation Guide for OEM Exporters

The EU Cosmetics Regulation (EC 1223/2009) is the legal framework governing cosmetic products in the European Union. It replaced the old Cosmetics Directive in 2009 and introduced several mandatory requirements that directly affect OEM manufacturers exporting to Europe.

CPNP (Cosmetic Products Notification Portal) is the EU's centralized electronic notification system. All cosmetic products must be notified via CPNP before they can be placed on the EU market.

Key Market Data

Who Must Notify?

The Responsible Person (RP) — defined by the Regulation as the EU-based entity that is responsible for placing the product on the EU market. The RP can be:

• The brand owner (if EU-based)
• An EU-based importer or distributor
• A designated EU representative (for non-EU brand owners — this is mandatory under the Regulation)

Important: Non-EU companies cannot directly notify CPNP. They must appoint an EU-based Responsible Person. This is one of the top rejection reasons — 37% of cosmetic listings fail because no EU RP is designated.

What Must Be Notified?

The following information must be submitted via CPNP before the product enters the EU market:

• Product category and subcategory
• Product name
• Responsible Person details (name, address, contact)
• Frame formulation (INCI ingredient list with concentration ranges, not exact percentages)
• Country of origin (e.g., China)
• Manufacturing site information
• Product Information File (PIF) location
• Safety assessment confirmation

When to Notify?

Products must be notified via CPNP before being placed on the EU market. For nano-materials, notification must be done at least 6 months before placing on the market.

Every cosmetic product sold in the EU must have a Product Information File (PIF). The PIF must be kept by the Responsible Person and accessible to authorities upon request.

PIF Contents:

• Product description: Name, category, intended use, target population
• Safety assessment (CPSR): Cosmetic Product Safety Report, conducted by a qualified Safety Assessor with a documented qualification in pharmacology, toxicology, or equivalent
• Evidence of claims: Proof that any marketing claims (e.g., "anti-aging", " moisturizing") are substantiated
• Animal testing declaration: Statement confirming no animal testing was conducted (EU ban since 2013)
• Manufacturing method: GMP compliance documentation — ISO 22716 certificate from the OEM factory
• Stability data: Physical, chemical, and microbiological stability under foreseeable storage conditions
• Microbial quality: Preservative efficacy test (challenge test) results and microbiological specifications
• Packaging information: Container materials, compatibility with the product, labeling compliance
• Labeling: Full label text meeting Regulation requirements (INCI list, batch number, PAO/expiry date, warnings, RP name and address)

One of the most common reasons for CPNP rejection (29% of all submissions) is incorrect INCI (International Nomenclature of Cosmetic Ingredients) naming.

INCI Rules You Must Follow:

• Use official INCI names: Not trade names, not common names, not Chinese names. Example: "Aqua" (not "Water" or "水"), "Glycerin" (not "Glycerol" or "甘油")
• Concentration ordering: Ingredients must be listed in descending order of concentration. Ingredients below 1% may be listed in any order after those at 1%+
• Color additives: Listed at the end using CI (Color Index) numbers
• Parfum/flavor: May use "Parfum" or "Aroma" as single terms for fragrance compositions
• Nano-materials: Must be marked with "(nano)" after the INCI name
• Regulated substances: Preservatives, UV filters, and colorants must use their Annex-specific names

How 8OEM helps: Every formulation from 8OEM comes with a correctly formatted INCI ingredient list, ready for CPNP submission. This eliminates the 29% INCI naming rejection rate — one of the biggest compliance pain points.

Key takeaway: If you sell in both EU and UK, you need two separate notifications (CPNP + SCPN) and two Responsible Persons (EU-based + UK-based). 8OEM provides documentation that supports both.

• ISO 22716:2007 GMP Certificate: Bureau Veritas issued (CNSH20273252-ISO22716) — satisfies the EU Regulation's GMP requirement (Article 11)
• Correctly formatted INCI ingredient lists: For every formulation, eliminating the 29% INCI rejection rate
• Stability data: Accelerated and real-time stability testing results for PIF inclusion
• Microbial challenge test reports: Preservative efficacy testing, eliminating the 21% microbial data rejection rate
• Batch records and QC documentation: Dual-language (English + Chinese), accessible for EU authority inspection
• Safety data sheets (SDS): For raw materials and finished products
• EU Responsible Person advisory: Guidance on appointing an EU-based RP — eliminating the 37% "no RP" rejection rate
• Animal testing declaration: Confirmation of no animal testing (EU ban compliance)

1. Choose an ISO 22716-certified OEM factory (8OEM: Bureau Veritas certified)
2. Request correctly formatted INCI ingredient lists from the factory
3. Appoint an EU-based Responsible Person (mandatory for non-EU brands)
4. Commission a Cosmetic Product Safety Report (CPSR) from a qualified Safety Assessor
5. Prepare the Product Information File (PIF) with all required documentation
6. Submit CPNP notification before placing the product on the EU market
7. For UK market: Submit SCPN notification separately with UK-based RP
8. Maintain PIF for 10 years after the last batch is placed on the market
9. Keep batch records accessible for EU authority inspection upon request